Vimarsana
Biggest News Aggregation in the World

Page 19 - Point Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Point Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Point Partners Today - Breaking & Trending Today

Vinod Khosla sees risk ahead but it's not AI he's most worried about - Vimarsana News

Vinod Khosla sees risk ahead but it's not AI he's most worried about

Khosla agrees that Biden administration cutting off advanced chips to China is the right move

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Shares Sold by Sphera Funds Management LTD. - Vimarsana News

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Shares Sold by Sphera Funds Management LTD.

Sphera Funds Management LTD. lessened its stake in shares of Gracell Biotechnologies Inc. (NASDAQ:GRCL – Free Report) by 48.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,228,665 shares of the company’s stock after selling 1,131,915 shares during the quarter. Sphera Funds Management […]

Source: wkrb13.com
Trexquant Investment LP Makes New Investment in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Vimarsana News

Trexquant Investment LP Makes New Investment in Alpine Immune Sciences, Inc. (NASDAQ:ALPN)

Trexquant Investment LP acquired a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 42,773 shares of the biotechnology company’s stock, valued at approximately $440,000. Trexquant Investment LP owned 0.09% of […]

62,839 Shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Bought by ExodusPoint Capital Management LP - Vimarsana News

62,839 Shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Bought by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP bought a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the second quarter, HoldingsChannel reports. The firm bought 62,839 shares of the biotechnology company’s stock, valued at approximately $646,000. A number of other hedge funds and other institutional investors have also recently modified their holdings […]

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells $203,276.08 in Stock - Vimarsana News

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells $203,276.08 in Stock

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Benjamin T. Dake sold 12,517 shares of the stock in a transaction on Monday, November 27th. The shares were sold at an average price of $16.24, for a total value of $203,276.08. Following the sale, the insider now directly owns 1,291 shares in the company, valued […]